1-7 of 7
Noreen Ersing
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Humanized Anti-Ganglioside GM2 Antibody, BIW-8962, Exhibits ADCC/CDC Activity against Multiple Myeloma Cells and Potent Anti- Tumor Activity in Mouse Xenograft Models.

Toshihiko Ishii, Asher Alban Chanan-Khan, MD, Jazur Jafferjee, MD, Noreen Ersing, Takeshi Takahashi, PhD, Masato Mizutani, PhD, Yukimasa Shiotsu, PhD, Nobuo Hanai, PhD
Journal: Blood
Blood (2008) 112 (11): 1718.
https://doi.org/10.1182/blood.V112.11.1718.1718
Published: 2008
Journal Articles

Survival Signals, Growth Cytokines, Immunosuppressive Factors and Their Cellular Perpetrators in the Myeloma Tumor Microenvironment.

Jayakumar R Nair, PhD, Louise M Carlson, PhD, Noreen Ersing, MS, Asher Alban Chanan-Khan, MD, Kelvin P. Lee, MD
Journal: Blood
Blood (2008) 112 (11): 1664.
https://doi.org/10.1182/blood.V112.11.1664.1664
Published: 2008
Journal Articles

Antiproliferative and Proapoptotic Effect of Vitamin D in Bortezomib (B) Resistant Human Myeloma Cell Line (HMCL).

Asher Alban Chanan-Khan, MD, Michelle Romano, Paula Pera, Noreen Ersing, Josephia Muindi, MD, Donald L. Trump, MD, Candace Johnson, MD
Journal: Blood
Blood (2006) 108 (11): 5074.
https://doi.org/10.1182/blood.V108.11.5074.5074
Published: 2006
Journal Articles

Characterization of Bortezomib Resistant Human Multiple Myeloma Cell Line (HMCL): A Clinically Relevant Model for Novel Drug Development in Multiple Myeloma (MM).

Asher Alban Chanan-Khan, MD, Noreen Ersing, Paula Pera, Ralph Bernaki, Ph.D., Lionel Coignet, Ph.D., David W. Goodrich, Ph.D., Raya Haung, Ph.D., Carl W. Porter, Ph.D.
Journal: Blood
Blood (2006) 108 (11): 5050.
https://doi.org/10.1182/blood.V108.11.5050.5050
Published: 2006
Journal Articles

Pro-Apoptotic Effect of Lenalidomide (L) in Patients with Chronic Lymphocytic Leukemia (CLL) Is Possibly Mediated through Interruption of the Phosphatidylinositol Pathway.

Asher Alban Chanan-Khan, MD, Noreen Ersing, Deborah Krammer, Ralph Bernacki, Lionel Coignet, David Goodrich, Naveen Bangia, Swami Padmanabhan, Carl W. Porter
Journal: Blood
Blood (2006) 108 (11): 2102.
https://doi.org/10.1182/blood.V108.11.2102.2102
Published: 2006
Journal Articles

First Clinical Evidence of In Vivo Natural Killer (NK) Cell Modulation in Chronic Lymphocytic Leukemia (CLL) Patients (pts) Treated with Lenalidomide (L).

Swaminathan Padmanabhan, MD, Noreen Ersing, Ph.D, Paul K. Wallace, Ph.D, Kena C. Miller, RNP, Laurie Musiel, RNP, Micheal Rickert, Asher Alban Chanan-Khan, MD
Journal: Blood
Blood (2006) 108 (11): 2109.
https://doi.org/10.1182/blood.V108.11.2109.2109
Published: 2006
Journal Articles

In Vivo Evaluation of Immunomodulating Effects of Lenalidomide (L) on Tumor Cell Microenvironment as a Possible Underlying Mechanism of the Antitumor Effects Observed in Patients (pts) with Chronic Lymphocytic Leukemia (CLL).

Asher Alban Chanan-Khan, MD, Swaminathan Padmanabhan, MD, Kena C. Miller, NP, Paula Pera, Laurie DiMiceli, Noreen Ersing, Paul Wallace, MD, Michael Rickert, Carl Porter, MD
Journal: Blood
Blood (2005) 106 (11): 2975.
https://doi.org/10.1182/blood.V106.11.2975.2975
Published: 2005